Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.
Tags
OMICS
LC/MS
LC/HRMS
LC/MS/MS
Preparing for next generation LC-MS based proteomics
Targeted and Non-Targeted Screening of Persistent Organic Pollutants (POPs) in Groundwater and Trade Effluent Wastewater Using the Xevo™ G3 QTof Mass Spectrometer